Literature DB >> 5899275

Pharmacological and toxicological studies on gamma-(4-methylpiperidino)-p-fluorobutyrophenone (FG 5111)--a new neuroleptic agent.

J A Christensen, S Hernestam, J B Lassen, N Sterner.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5899275     DOI： 10.1111/j.1600-0773.1965.tb03578.x

Source DB:  PubMed          Journal:  Acta Pharmacol Toxicol (Copenh)        ISSN： 0001-6683


× No keyword cloud information.
  7 in total

1.  Cardiac electrophysiology of four neuroleptics: melperone, haloperidol, thioridazine and chlorpromazine.

Authors:  P Arlock; B Gullberg; S R Olsson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1978-08       Impact factor: 3.000

2.  Monoamine metabolite levels in cerebrospinal fluid of psychotic women treated with melperone or thiothixene.

Authors:  L Bjerkenstedt; B Gullberg; C Härnryd; G Sedvall
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-10-11

3.  Effects of melperone and thiothixene on prolactin levels in cerebrospinal fluid and plasma of psychotic women.

Authors:  L Bjerkenstedt; P Eneroth; C Härnryd; G Sedvall
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1977-12-28

4.  New dystonic syndrome associated with butyrophenone therapy.

Authors:  K Ekbom; H Lindholm; L Ljungberg
Journal:  Z Neurol       Date:  1972

5.  A double-blind comparison of melperone and thiothixene in psychotic women using a new rating scale, the CPRS.

Authors:  L Bjerkenstedt; C Härnryd; V Grimm; B Gullberg; G Sedvall
Journal:  Arch Psychiatr Nervenkr (1970)       Date:  1978-12-14

6.  Pharmacokinetics of parenteral and oral melperone in man.

Authors:  L Borgström; H Larsson; L Molander
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Differential actions on rabbit nodal, atrial, Purkinje cell and ventricular potentials of melperone, a bradycardic agent delaying repolarization: effects of hypoxia.

Authors:  J S Millar; E M Vaughan Williams
Journal:  Br J Pharmacol       Date:  1982-01       Impact factor: 8.739
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.